News Release

Plasma amyloid assay as a pre-screening tool for amyloid positron emission tomography imaging in early stage Alzheimer’s disease

SY Lin, KJ Lin, PC Lin, CC Huang, CC Chang, YC Lee, IT Hsiao, TC Yen, WS Huang, BH Yang and PN Wang...

more

Advance in Plasma AD Core Biomarker Development: Current Findings from Immunomagnetic Reduction-Based SQUID Technology

Lih-Fen Lue . Yu-Min Kuo . Marwan Sabbagh Neurol Ther (2019) 8 (Suppl 2):S95–S111

more

Combined Assessment of Serum Alpha-Synuclein and Rab35 is a Better Biomarker for Parkinson's Disease

HL Wang, CS Lu, TH Yeh, YM Shen, YH Weng, YZ Huang, RS Chang, YL Chen, YJ Chen, YW Lin, CC Hsu, HL...

more

Associations between Plasma Biomarkers and Cognition in Patients with Alzheimer’s Disease and Amnestic Mild Cognitive Impairment: A Cross-Sectional and Longitudinal Study

Tsai CL, Liang CS, Lee JT, Su MW, Lin CC, Chu HT, Tsai CK, Lin GY, Lin YK and Yang FC J....

more

Plasma pS129-α-Synuclein Is a Surrogate Biofluid Marker of Motor Severity and Progression in Parkinson’s Disease

Lin CH, Liu HC, Yang SY, Yang KC, Wu CC and Chiu MJ Plasma pS129-α-Synuclein Is a Surrogate...

more

Pages